Healthcare Dealmaking Symposium
|
|
Proskauer Rose LLP partner Richard J. Zall spoke at The Deal's Healthcare Dealmaking Conference on potential unknown liabilities involved in healthcare M&A. - George White...
Continue Reading
| |
|
|
Fiona Schaeffer, a partner at Weil, Gotshal & Manges, spoke at The Deal's Healthcare Dealmaking Conference on increasing difficulties surrounding regulatory approvals for healthcare M&A. "I think these cases raise a perfect storm of regulatory intervention that not everyone who is following this industry is always aware of. The perfected storm consists of not only the Department of Justice in Washington, but also by the State Attorney General and insurance commissioners in the relevant states where the companies are doing business. So, in any one transaction, you can see yourself needing not only approval from the Feds, but also some...
Continue Reading
| |
|
|
David P. Wales Jr., deputy director of the Federal Trade Commission's Bureau of Competition, discussed how the FTC evaluates hospital mergers and pharmaceutical mergers and its ongoing investigations at The Deal's Healthcare Dealmaking Symposium. - Maria Woehr...
Continue Reading
| |
|
|
Chul Pak, a partner at Wilson Sonsini Goodrich & Rosati, discussed the regulatory outlook for healthcare over the next year at The Deal's Healthcare Dealmaking Symposium. Pak also addressed negotiating strategies with the Federal Trade Commission and the court systems when conducting divestments and acquisitions....
Continue Reading
| |
|
|
Nathaniel Zilkha, a principal at Kohlberg Kravis Roberts & Co., spoke at The Deal's Healthcare Dealmaking Symposium about rising costs, managed care and healthcare reform. "There's no political will to deal with [healthcare costs] now, but at some point the arithmetic is going to overwhelm the inertia," Zilkha said. Watch the video after the jump. - George White...
Continue Reading
| |
|
|
Jonathan Korngold, a managing director at General Atlantic LLC, discussed international M&A opportunities within healthcare at the The Deal's Healthcare Dealmaking Symposium. In the video after the jump, he talks about some of General Atlantic's investments in hospitals and laboratories. "The beauty of healthcare is its one of the most local industries, but it's also one of the most global industries that affects everyone regardless of the economy," he said. - Maria Woehr...
Continue Reading
| |
|
|
Chris Gordon, a principal at Bain Capital LLC, spoke at The Deal's Healthcare Dealmaking Symposium about Bain Capital's acquisition of Quintiles Transnational Corp., a clinical research service for biotech and pharmaceutical companies. "It has a fundamental growth to make this an interesting deal to us," he stated. -Maria Woehr...
Continue Reading
| |
|
|
Nathaniel Zilkha, a principal at KKR, spoke at The Deal's Healthcare Dealmaking Symposium about the counter-cyclical dynamics in healthcare M&A that his firm is seeing. ...
Continue Reading
| |
|
|
Jonathan Korngold, a managing director at General Atlantic LLC, addressed M&A opportunities within healthcare over the next two years at The Deal's Healthcare Dealmaking Symposium. Korngold predicts that within the next 12 to 18 months there will be some great reimbursement opportunities for investors. "I'm quite optimistic about the prospects in healthcare over the next 24 months," he said. - Maria Woehr...
Continue Reading
| |
|
|
John Leone, a partner at Paul Capital Healthcare, appeared at The Deal's Healthcare Dealmaking Symposium to discuss investment in the intellectual properties of universities and small companies. In a video clip from the conference, Leone discusses some of the firm's investments and explains that even though there is a debt crisis, investment in small companies is necessary. "There are still deals out there for the smaller companies. They still need to grow -- either that or they are going to go away," he said. - Maria Woehr...
Continue Reading
| |
|
|
Michael J. Kluger, a managing director at Altaris Capital Partners LLC, spoke about the middle market at The Deal's Healthcare Dealmaking Symposium. In a panel discussion, Kluger discussed the ways new innovations in financing midmarket healthcare deals have allowed M&A activity in that sector to continue thriving. - George White ...
Continue Reading
| |
|
|
Benjamin Edmands, managing director of CCMP Capital Advisors LLC, discussed investing in healthcare at The Healthcare Dealmaking Symposium. In this clip Edmands answers a question from Michael Kaplan, managing director, healthcare team leader at Standard & Poor's, concerning challenges and trends within the healthcare market. Edmands also outlines CCMP's investment in not-for-profit health systems. - Maria Woehr...
Continue Reading
| |
|
|
Benjamin Edmands, managing director of CCMP Capital Advisors LLC, discussed investing in healthcare at The Deal's Healthcare Dealmaking Symposium....
Continue Reading
| |
|
|
Ken Hitchner, the global head of Healthcare Investment Banking at Goldman, Sachs & Co., spoke with The Deal's Mary Kathleen Flynn at the Healthcare Dealmaking Symposium, where he touched on the industry's M&A prospects, debt markets and where his firm is looking internationally. play_blip_movie_784739();...
Continue Reading
| |
|
|
Healthcare technology is an everchanging facet of the sector where deals are happening, but the atmosphere for deals has been hampered by the niche technology....
Continue Reading
| |
|
|
Wrapping up The Deal's Healthcare Dealmaking Symposium was a panel discussion titled "Licensing Deals." The discussion was moderated by Patrick Clinton, editor in chief of Pharmaceutical Executive; the panelists included Annarie Lyles, head of corporate development at Genmab Inc., and Robert Knowles, senior director of worldwide business development at Pfizer Inc....
Continue Reading
| |
|
|
At The Deal's Healthcare Dealmaking Symposium, members of a panel entitled "Regulatory Landscape Facing the Healthcare Industry" analyzed the various viewpoints within an industry that persistently faces issues of antitrust violation and enforcement. Moderated by The Deal's senior writer Cecile Kohrs Lindell, the panel featured Chul Pak, a partner at Wilson Sonsini Goodrich & Rosati; Fiona Schaeffer, a partner at Weil, Gotshal & Manges LLP; David P. Wales Jr., the deputy director of the Bureau of Competition at the Federal Trade Commission; and Richard J. Zall, a partner at Proskauer Rose LLP....
Continue Reading
| |
|
|
At Wednesday's The Deal's Healthcare Dealmaking Symposium in New York, panelist Christine Arakelian, vice president, business development for Omnicare Inc., said she puts integration into two buckets. The first she calls "step-out acquisitions" that immediately get folded into an existing facility. The procedures for these quick integrations are standardized and include a "SWAT team" that trains regional teams on the ground to get companies integrated efficiently....
Continue Reading
| |
|
|
A group of private equity professionals discussed what's on the radar for the healthcare M&A market in 2008 at The Deal's Healthcare Dealmaking Symposium Wednesday morning. Moderated by Michael J. Kaplan, a managing director with Standard & Poor's corporate ratings healthcare team, the panelists looked at managed care, the distress among hospitals and what's on the reform front. "I'm quite optimistic about healthcare over the next 12 months," said Jonathan Korngold, a managing director at General Atlantic LLC. "The debt slowdown is a welcome respite for us; over the next 12 to 18 months, there's going to be some great...
Continue Reading
| |
|
|
During the keynote interview at The Deal's Healthcare Dealmaking Symposium, The Deal's Scott Stuart interviewed Vicky Gregg, president and CEO of BlueCross BlueShield of Tennessee. Highlights of their conversation included a discussion of spiraling costs, the advent of consumerism in managed care and the role of technology in healthcare....
Continue Reading
| |
Browse past entries in the Healthcare Dealmaking Symposium category by date
|
Search
Editor's Choice
Syndicate
Recent Entries
Video
Categories
Monthly Archives
Blog Roll
|
E-mail |
Leave a Comment
